Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells

Journal of Visualized Experiments

Volumn 2015, Issue 99, 2015, Pages

  Horibata, Sachi ^a   Vo, Tommy V ^a   Subramanian, Venkataraman ^b   Thompson, Paul R ^b   Coonrod, Scott A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Cancer therapies; Cellular transformation; Issue 99; Medicine; Peptidylarginine deiminase enzymes; Soft agar assay

Indexed keywords

AGAR; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; HYDROLASE; N-ALPHA-BENZOYL-N5-(2-CHLORO-1-IMINOETHYL)-L-ORNITHINE AMIDE; ORNITHINE; PROTEIN-ARGININE DEIMINASE; SEPHAROSE;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CANCER STEM CELL; CARCINOGENESIS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; CHEMISTRY; DISEASE COURSE; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; FEMALE; HUMAN; PATHOLOGY; TUMOR CELL LINE;

AGAR; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOGENESIS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROLASES; NEOPLASTIC STEM CELLS; ORNITHINE; SEPHAROSE;

EID: 84941254807     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52727     Document Type: Article

References (11)

1. Hamburger, A. W., Salmon, S. E. Primary bioassay of human tumor stem cells. Science. 197, 461-463 (1977).
2. Wang, L. H. Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med. 71, (6), 361-367 (2004).
3. Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J., Pruijn, G. J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 25, (11), 1106-1118 (2003).
4. Horibata, S., Coonrod, S. A., Cherrington, B. D. Role for peptidylarginine deiminase enzymes in disease and female reproduction. J Reprod Dev. 58, (3), 274-282 (2012).
5. Mohanan, S., Cherrington, B. D., Horibata, S., McElwee, J. L., Thompson, P. R., Coonrod, S. A. Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem Res Int. 895343 (2012).
6. McElwee, J. L., et al. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer. 12, 500 (2012).
7. Knight, J. S., et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis. 1-8 (2014).
8. Miller, F. R., Santner, S. J., Tait, L., Dawson, P. J. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl cancer Inst. 92, 1185-1186 (2000).
9. Fan, D., Morgan, L. R., Schneider, C., Blank, H., Fan, S. Cooperative evaluation of human tumor chemosensitivity in the soft-agar assay and its clinical correlations. J Cancer Res Clin Oncol. 109, 23-28 (2000).
10. Hamburger, A. W., White, C. P., Dunn, F. E., Citron, M. L., Hummel, S. Modulation of human tumor colony growth in soft agar by serum. Int J Cell Cloning. 1, (4), 216-229 (1983).
11. Anderson, S. N., Towne, D. L., Burns, D. J., Warrior, U. A high-throughput soft agar assay for identification of anticancer compound. J Biomol Screen. 12, 938-945 (2007).